호기산화질소 측정을 이용한 천식 치료

키워드

참고문헌 (35)

1. "Global Strategy for Asthma Management and Prevention" (2017)[URL]
2. Maniscalco M, "Fractional exhaled nitric oxide-measuring devices: technology update", Med Devices (Auckl), 9, pp.151~160 (2016)
3. 송우정, "Clinical Application of Exhaled Nitric Oxide Measurements in a Korean Population", Allergy, Asthma & Immunology Research, 7(1), pp.3~13 (2015), 대한천식알레르기학회
4. Kim SH, "Comparison of two exhaled nitric oxide analyzers: the NIOX MINO hand-held electrochemical analyzer and the NOA280i stationary chemiluminescence analyzer", Respirology, 17, pp.830~834 (2012)
5. "Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the american thoracic society was adopted by the ATS board of directors, July 1999", Am J Respir Crit Care Med, 160, pp.2104~2117 (1999)
6. "ATS", ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005, 2005, pp.171, 912~930
7. Mummadi SR, "Update on exhaled nitric oxide in clinical practice", Chest, 149, pp.1340~1344 (2016)
8. Karrasch S, "Accuracy of FENO for diagnosing asthma: a systematic review", Thorax, 72, pp.109~116 (2017)
9. Guo Z, "Diagnostic accuracy of fractional exhaled nitric oxide in asthma: a systematic review and meta-analysis of prospective studies", J Asthma, 53, pp.404~412 (2016)
10. Olin AC, "Fraction of exhaled nitric oxide at 50 mL", s: reference values for adult lifelong never-smokers, 2007, pp.131, 1852~1856
11. Kim SH, "Reference values and determinants of exhaled nitric oxide in healthy Korean adults", J Asthma, 47, pp.563~567 (2010)
12. Oh MJ, "Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough", Chest, 134, pp.990~995 (2008)
13. Dweik RA, "An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications", Am J Respir Crit Care Med, 184, pp.602~615 (2011)
14. Donohue JF, "Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates", Respir Med, 107, pp.943~952 (2013)
15. Smith AD, "Exhaled nitric oxide:a predictor of steroid response", Am J Respir Crit Care Med, 172, pp.453~459 (2005)
16. Woodruff PG, "T-helper type 2-driven inflammation defines major subphenotypes of asthma", Am J Respir Crit Care Med, 180, pp.388~395 (2009)
17. Cowan DC, "Biomarker-based asthma phenotypes of corticosteroid response", J Allergy Clin Immunol, 135, pp.877~883 (2015)
18. Bates CA, "Exhaled nitric oxide in asthma: from bench to bedside", J Allergy Clin Immunol, 111, pp.256~262 (2003)
19. Pijnenburg MW, "Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial", Am J Respir Crit Care Med, 172, pp.831~836 (2005)
20. Shaw DE, "The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial", Am J Respir Crit Care Med, 176, pp.231~237 (2007)
21. Smith AD, "Use of exhaled nitric oxide measurements to guide treatment in chronic asthma", N Engl J Med, 352, pp.2163~2173 (2005)
22. Petsky HL, "Exhaled nitric oxide levels to guide treatment for adults with asthma", Cochrane Database Syst Rev, 9, pp.CD011440~ (2016)
23. Honkoop PJ, "Symptomand fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care", J Allergy Clin Immunol, 135, pp.682~688 (2015)
24. Calhoun WJ, "Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial", JAMA, 308, pp.987~997 (2012)
25. Syk J, "Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial", J Allergy Clin Immunol Pract, 1, pp.639~648 (2013)
26. Hashimoto S, "Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial", Thorax, 66, pp.514~520 (2011)
27. Chung KF, "International ERS", ATS guidelines on definition, evaluation and treatment of severe asthma, 2014, pp.43, 343~373
28. 김상헌, "중증 천식의 임상적, 병태생리적 특징", 대한내과학회지, 83(4), pp.424~429 (2012), 대한내과학회[DOI]
29. McNicholl DM, "The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma", Am J Respir Crit Care Med, 186, pp.1102~1108 (2012)
30. Matteo Ferrando, "Personalized Medicine in Allergy", Allergy, Asthma & Immunology Research, 9(1), pp.15~24 (2017), 대한천식알레르기학회
31. Agusti A, "Treatable traits: toward precision medicine of chronic airway diseases", Eur Respir J, 47, pp.410~419 (2016)
32. Parulekar AD, "Role of T2 inflammation biomarkers in severe asthma", Curr Opin Pulm Med, 22, pp.59~68 (2016)
33. Malinovschi A, "Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in national health and nutrition examination survey subjects", J Allergy Clin Immunol, 132, pp.821~827 (2013)
34. Merritt L. Fajt, "Development of New Therapies for Severe Asthma", Allergy, Asthma & Immunology Research, 9(1), pp.3~14 (2017), 대한천식알레르기학회
35. Kim SH, "Use of the exhaled nitric oxide for management of asthma and respiratory diseases", Korean J Med, 74, pp.579~586 (2008)

관련 논문AI추천